BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND MAP2K4, MEK4, 6416, P45985, ENSG00000065559, SERK1, JNKK1, MKK4, PRKMK4, MAPKK4, JNKK, SEK1 AND Treatment
16 results:

  • 1. Small-molecule inhibition of map2k4 is synergistic with RAS inhibitors in
    Jansen RA; Mainardi S; Dias MH; Bosma A; van Dijk E; Selig R; Albrecht W; Laufer SA; Zender L; Bernards R
    Proc Natl Acad Sci U S A; 2024 Feb; 121(9):e2319492121. PubMed ID: 38377196
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Yttrium-90 Transarterial Radioembolization of Primary lung cancer Metastases to the Liver.
    Alexander ES; Petre EN; Zhao K; Sotirchos V; Namakydoust A; Moussa A; Yuan G; Sofocleous CT; Solomon SB; Ziv E
    J Vasc Interv Radiol; 2024 Feb; 35(2):214-225.e2. PubMed ID: 37923172
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Network Pharmacology-Based Identification of Key Pharmacological Mechanism of Shen-qi-di-huang Decoction Acting on Uremia.
    Zhang X; Chen XF; Chen WJ; Ding H; Zhang BX
    Altern Ther Health Med; 2024 Jan; 30(1):44-50. PubMed ID: 37773677
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Deep learning to estimate lung disease mortality from chest radiographs.
    Weiss J; Raghu VK; Bontempi D; Christiani DC; Mak RH; Lu MT; Aerts HJWL
    Nat Commun; 2023 May; 14(1):2797. PubMed ID: 37193717
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Cost‑Effectiveness of Lorlatinib in First-Line treatment of Adult Patients with Anaplastic Lymphoma Kinase (ALK)‑Positive Non‑Small‑Cell lung cancer in Sweden.
    Naik J; Beavers N; Nilsson FOL; Iadeluca L; Lowry C
    Appl Health Econ Health Policy; 2023 Jul; 21(4):661-672. PubMed ID: 37173513
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Analysis of survival of patients with metastatic malignant pleural mesothelioma.
    Billè A; Okiror L; Harling L; Pernazza F; Muzio A; Roveta A; Grosso F
    Tumori; 2021 Apr; 107(2):110-118. PubMed ID: 32458750
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Pulmonary carcinosarcoma: analysis from the Surveillance, Epidemiology and End Results database.
    Sun L; Dai J; Wang X; Jiang G; Gonzalez-Rivas D; Song J; Zhang P
    Interact Cardiovasc Thorac Surg; 2020 Jan; 30(1):4-10. PubMed ID: 31518405
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Synergistic antimetastatic effect of cotreatment with licochalcone A and sorafenib on human hepatocellular carcinoma cells through the inactivation of mkk4/JNK and uPA expression.
    Wu MH; Chiu YF; Wu WJ; Wu PL; Lin CY; Lin CL; Hsieh YH; Liu CJ
    Environ Toxicol; 2018 Dec; 33(12):1237-1244. PubMed ID: 30187994
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. TGFβ-Induced lung cancer Cell Migration Is NR4A1-Dependent.
    Hedrick E; Mohankumar K; Safe S
    Mol Cancer Res; 2018 Dec; 16(12):1991-2002. PubMed ID: 30072581
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Functional cooperation between HIF-1α and c-Jun in mediating primary and acquired resistance to gefitinib in NSCLC cells with activating mutation of EGFR.
    Meng S; Wang G; Lu Y; Fan Z
    Lung Cancer; 2018 Jul; 121():82-90. PubMed ID: 29858032
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. cAMP signaling increases histone deacetylase 8 expression via the Epac2-Rap1A-Akt pathway in H1299 lung cancer cells.
    Park JY; Juhnn YS
    Exp Mol Med; 2017 Feb; 49(2):e297. PubMed ID: 28232663
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. CIP2A overexpression induces autoimmune response and enhances JNK signaling pathway in human lung cancer.
    Peng B; Chai Y; Li Y; Liu X; Zhang J
    BMC Cancer; 2015 Nov; 15():895. PubMed ID: 26560124
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Mitogen-activated protein kinase phosphatase-1 modulated JNK activation is critical for apoptosis induced by inhibitor of epidermal growth factor receptor-tyrosine kinase.
    Takeuchi K; Shin-ya T; Nishio K; Ito F
    FEBS J; 2009 Mar; 276(5):1255-65. PubMed ID: 19175673
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells.
    Khatlani TS; Wislez M; Sun M; Srinivas H; Iwanaga K; Ma L; Hanna AE; Liu D; Girard L; Kim YH; Pollack JR; Minna JD; Wistuba II; Kurie JM
    Oncogene; 2007 Apr; 26(18):2658-66. PubMed ID: 17057737
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Evidence that phosphatidylinositol 3-kinase- and mitogen-activated protein kinase kinase-4/c-Jun NH2-terminal kinase-dependent Pathways cooperate to maintain lung cancer cell survival.
    Lee HY; Srinivas H; Xia D; Lu Y; Superty R; LaPushin R; Gomez-Manzano C; Gal AM; Walsh GL; Force T; Ueki K; Mills GB; Kurie JM
    J Biol Chem; 2003 Jun; 278(26):23630-8. PubMed ID: 12714585
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Inhibition of oncogenic K-ras signaling by aerosolized gene delivery in a mouse model of human lung cancer.
    Lee HY; Suh YA; Lee JI; Hassan KA; Mao L; Force T; Gilbert BE; Jacks T; Kurie JM
    Clin Cancer Res; 2002 Sep; 8(9):2970-5. PubMed ID: 12231543
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.